Clinical Presentation, Risk Factors, and Cross-Protection from Repeated Respiratory Viral Infections in Infants in Nepal

Among the leading risk factors for the development of emergency conditions in acute intestinal infections, especially in infants, some authors point to rickets, anemia, and abnormal antenatal pathology. The aim is to determine the frequency of occurrence of various risk factors for the development of emergency situations in tender-age infants. Materials and methods: 338 tender-age infants with urgent conditions were under observation. The study involved clinical-anamnestic, bacteriological, and serological methods. The aggravating factors were as follows: diseases of parents in 16 (6.2%), related marriages - 20 (7.7%) pregnancy pathology-137 (52.9%), prematurity-16 (6.2%), artificial feeding - 127 (49.0%), early diseases (acute respiratory viral infections, pneumonia, encephalopathy, intestinal infections). Results: According to the results of the study, the central nervous system damage was most often observed in children from 1 month to 6 months (80.2%), anemia was more detected in children of 1-3 years - 56.4%, rickets was more diagnosed in children aged 6-12 months -38.2%.

Download Full-text

RESPIRATORY VIRAL INFECTIONS IN PEDIATRIC INTENSIVE CARE UNIT OVER 5 YEARS- EPIDEMIOLOGY AND RISK FACTORS FOR SEVERE OUTCOME

10.26226/morressier.58fa1767d462b80290b514bf ◽

2017 ◽

Author(s):

Yael Shachor-Meyouhas

Keyword(s):

Risk Factors ◽

Intensive Care Unit ◽

Intensive Care ◽

Pediatric Intensive Care Unit ◽

Viral Infections ◽

Pediatric Intensive Care ◽

Respiratory Viral Infections

Download Full-text

Risk factors for respiratory viral infections in newborns

Kazan medical journal ◽

10.17816/kazmj84053 ◽

1981 ◽

Vol 62 (5) ◽

pp. 24-26

Author(s):

O. I. Pikuza ◽

L. A. Kuznetsova ◽

L. Y. Aleksandrova

Keyword(s):

Risk Factors ◽

Respiratory Diseases ◽

Viral Infections ◽

Expectant Mother ◽

Increased Risk ◽

Negative Effect ◽

Acute Respiratory Diseases ◽

The Central Nervous System ◽

Respiratory Viral Infections ◽

The Impact

The study of the clinical features of acute respiratory viral infections and pneumonia in 320 newborns made it possible to identify a group of children with an increased risk of an unfavorable course of the disease. A negative effect on the prognosis of acute respiratory diseases in newborns is exerted by toxicosis, acute diseases of women during pregnancy, the impact on the expectant mother of occupational health problems, a burdened obstetric history, prematurity of the newborn, natal trauma of the central nervous system. Specific regimens have been developed to complement the conventional medical history that can facilitate the management of risk conditions and a differentiated approach to the newborn.

Download Full-text

Prevalence and Risk Factors of Respiratory Viral Infections in Exacerbations of Chronic Obstructive Pulmonary Disease

The Tohoku Journal of Experimental Medicine ◽

10.1620/tjem.240.131 ◽

2016 ◽

Vol 240 (2) ◽

pp. 131-139 ◽

Cited By ~ 6

Author(s):

Hyun Jung Kwak ◽

Dong Won Park ◽

Jee Eun Kim ◽

Min Kyung Park ◽

Gun Woo Koo ◽

...

Keyword(s):

Risk Factors ◽

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Viral Infections ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Respiratory Viral Infections

Download Full-text

Risk factors for acute respiratory viral infections in pregnant women. Effectiveness of preventive measures

Voprosy ginekologii akušerstva i perinatologii ◽

10.20953/1726-1678-2021-3-85-91 ◽

2021 ◽

Vol 20 (3) ◽

pp. 85-91

Author(s):

L.V. Kuklina ◽

◽

E.N. Kravchenko ◽

M.A. Ozherelyeva ◽

E.A. Zadorozhnaya ◽

...

Keyword(s):

Diabetes Mellitus ◽

Risk Factors ◽

Pregnant Women ◽

Viral Infections ◽

Preventive Treatment ◽

Main Group ◽

Second Phase ◽

Vitamins E And C ◽

Respiratory Viral Infections ◽

Tract Infections

Objective. To identify risk factors for acute respiratory viral infections (ARVI) (influenza and novel coronavirus infection (NCI) COVID-19) in pregnant women and evaluate the effectiveness of pharmacological prevention. Patients and methods. During the first phase, 152 individual medical records of pregnant women were retrospectively studied: 102 women (the first main group) with acute respiratory viral infections and 50 pregnant women who had no acute respiratory viral infections (the control group). The second phase was a prospective comparative study: the second main group (n = 100) – pregnant women who received recombinant interferon α-2b (IFN-α2b) with vitamins E and C as preventive treatment; the comparison group (n = 100) – without preventive treatment. Results. Risk factors for the incidence of ARVI included anemia (χ2 = 0.003), obesity (χ2 = 0.026), cardiovascular diseases (χ2 = 0.060), diabetes mellitus (χ2 = 0.050), frequent ARVI in medical history (χ2 = 0.028), nicotine intoxication (χ2 = 0.008), urinary tract infections (χ2 < 0.001). The second phase: 10% of pregnant women who received preventive treatment had mild forms of influenza and NCI; 2% of women had a moderate form. In the second main group, 33% of pregnant women were sick (OR = 2.852, 95% CI = 1.354–6.005, χ2 = 0.005): 26% of women had a mild form, 6% of women had a moderate form and 1% of women had a severe form. In the second main group, threatened miscarriage (χ2 < 0.001), preterm birth (χ2 < 0.001), gestational pyelonephritis (χ2 = 0.006), placental insufficiency (χ2 < 0.001), pre-eclampsia (χ2 = 0.006), congenital anomalies of the fetus (χ2 = 0.017) and intrauterine infection (χ2 < 0.001) were more frequent. Conclusions. Among risk factors for ARVI during pregnancy were anemia, obesity, diabetes mellitus, and nicotine intoxication. Preventive treatment with recombinant IFNα-2b with vitamins E and C reduced the incidence of acute respiratory viral infections in pregnant women by 2.8 times and improved perinatal outcomes by 4.7 times. Key words: pregnancy, acute respiratory viral infections, prevention

Download Full-text

ARVI and pregnancy: prevention options

Voprosy ginekologii akušerstva i perinatologii ◽

10.20953/1726-1678-2020-6-145-152 ◽

2020 ◽

Vol 19 (6) ◽

pp. 145-152

Author(s):

L.V. Posiseeva ◽

◽

D.S. Kuksa ◽

◽

Keyword(s):

Risk Factors ◽

Viral Infections ◽

Newborn Health ◽

Pregnancy Risk ◽

Recombinant Interferon ◽

Her Family ◽

Perinatal Pathology ◽

Interferon Alpha 2B ◽

Respiratory Viral Infections ◽

The Impact

This paper addresses the main issues related to the incidence of Acute Respiratory Viral Infections (ARVI), including influenza and COVID-19, in pregnant women, the impact of these infections on the pregnancy course, fetal and newborn health. Risk factors for ARVI complications have been determined, taking into account the pregnancy term, the woman’s age and concomitant somatic diseases. A special attention was given to the specific (vaccination) and nonspecific ARVI prevention (the use of recombinant interferon alpha-2b, the medicine Grippferon) during the pregnancy preparation stage not only for the expectant mother, but also for all her family members. The results of the effective use of the interferon-based medicine Grippferon for the prevention and treatment of ARVI during pregnancy are provided. This medicine helps to reduce the frequency of ARVI-related pregnancy complications and perinatal pathology. Keywords: acute respiratory viral infections, pathogens, pregnancy, risk factors, prevention, interferon-based medicines, Grippferon

Download Full-text